Daegu Gyeongbuk Institute of Science and Technology
发明人:
申请号：
EP18756838.1
公开号：
EP3587443A1
申请日:
2018.02.27
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
A peptide according to the present invention has a simple structure compared to existing natural human erythropoietin, thus being able to easily pass through a tissue-blood barrier, has excellent bioactivity with respect to cell-protecting activity, has a low manufacturing cost, thus being economically advantageous, and does not have side effects on cell proliferation. Accordingly, a pharmaceutical composition containing the erythropoietin-derived peptide according to the present invention as an active ingredient may be usefully used for preventing or treating cell damage-related illnesses, such as stroke, mechanical damage or ischemic damage to the nervous system, myocardial infarction, retinal damage, and diabetes, and as a pharmaceutical composition for preventing cell damage.
